The CDC published a new recommendation this week calling for some adults ages 50 to 59 to get vaccinated for respiratory syncytial virus (RSV).

Adults as young as 50 may now qualify for an respiratory synctial virus vaccine if they have certain health conditions.

The CDC Advisory Committee on Immunization Practices February meeting covered vaccinations for COVID-19, influenza, RSV, and pneumococcal infections.

All New Yorkers ages 75 and older should receive the RSV vaccine heading into the fall and winter months, unless they previously got the shot, according to updated federal guidance. The Centers ...

The Trump administration appears to be expanding RSV vaccinations to some adults starting at age 50 instead of 60. Health ...

The Centers for Disease Control and Prevention (CDC) updated its RSV vaccine guidance for seniors for this upcoming respiratory viral season, saying the new recommendations are meant to simplify ...

The updated recommendation is designed to make decision-making about the RSV vaccine easier for health care workers and the public.

RSV vaccines for babies, older adults and pregnant people are in the works from several companies. Here's the latest data and information.

The RSV vaccine is not currently an annual vaccine, meaning people do not need to get a dose every RSV season, which typically starts in the fall and peaks in winter, the CDC says.

The CDC updated its recommendation for RSV vaccines to include everyone 75 and older, at those 60-74 who are at increased risk.